AMIX (autonomix.com) צמיחת רווח למניה השנה

Autonomix Medical, Inc. (AMIX) margins are based on the implementation of AI controllers in catheter systems to automate neuromonitoring. The annual growth rate of net income per share visualizes the market reaction to these innovations, while 0.00 indicates the current level. Revenues are growing through the sale of consumables for hypertension treatment, and a diversified microchip supply chain ensures assembly stability.

Autonomix Medical, Inc. (AMIX) focuses on the clinical scaling of microcatheter systems for oncological pain therapy. The year-over-year (YoY) percentage change in earnings per share quantifies the efficiency of R&D expenditures and FDA documentation preparation relative to the previous year. This indicator measures the speed of the business's adaptation to the cost of capital; therefore, the YoY net income per share trend serves as a navigator for the startup's financial stability.